Key Highlights: Q1 FY26

Announcing the results, Dr Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said,

“Market placement during the first quarter of the year benefited from an early onset of monsoon. Global demand has also started showing signs of recovery in a few of our products.

Our revenue for Q1 FY26 was at ₹957 Cr, 22% higher than ₹783 Cr of Q1 FY25. Profit After Tax (PAT) was ₹95 Cr in Q1 FY 26 as compared to ₹ 48 Cr in Q1 FY 25. We witnessed double-digit volume-led growth of 13% in Crop Care B2C, 23% in Crop Care B2B and 38% in Seeds business. Our Soil & Plant Health business registered growth of 33% in line with our strategy. Our actions on improving product mix and driving cost optimization have also helped in improving PAT margins from 6% in Q1FY 25 to 10% in Q1 FY 26.  We are pleased with the continuing momentum on our North Cotton seeds hybrids, particularly “Diggaz”. Our working capital management has also been robust, leading to a healthy closing fund balance.

We remain cautiously optimistic for the quarter ahead. Key watchouts will be the liquidation of placed products in both Crop Care B2C and Seeds. We expect the export market to witness a gradual recovery during the year.

On a long-term basis, Customer Centricity will remain a key thrust, and we will continue to offer differentiated solutions to solve varying farmer needs. We will further intensify our efforts to build capabilities in Manufacturing, Digitalization and leverage Collaborations and Alliances”.

Key Developments: Q1 FY26

• Successful Key New Products launches:

o    Crop Protection: Launched 9 new products across Herbicides, Fungicides and Insecticides. Key launches

• Allato (Oxadiargyl 1% + Pretilachlor 6% GR), Herbicide for Paddy
• Penflor (Florpyrauxifen-benzyl 1.31% + Penoxsulam 2.1% OD), Herbicide for Paddy
• Deweed (Paraquat 24% + Oxyfluorfen 5% SC), Non-selective Herbicide
• Dodrio (Thifluzamide 9% + Difenoconazole 6% + Validamycin 3% SC), Fungicide for Paddy sheath blight
• Master Gold (Metalaxyl M4% + Mancozeb 64% WP), Fungicide for Grapes
• Fiplam (Fipronil 12.5% + Lambda 5% ZC), 9(3), Insecticide for Cotton

o   Seeds: Launched 14 new products across Cotton, Bajra and Paddy

• Ankleshwar Unit received -“Resilient Award” Water Conservation jointly presented by SGCCI and GPCB
• Rallis has been awarded for “Best Supply Chain & Logistics company” by Alden Global
• Rallis has been awarded “Best CSR Initiative” for Krishi Vikram by Indian Chamber of Commerce

The post Rallis India Limited reports Revenue growth of 22%, PAT growth of 100% in Q1 FY 26  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Board recommends dividend of ₹ 2.50 per equity share

The post Rallis India Limited reports FY25 Revenue at ₹ 2663 Cr and PAT at ₹ 125 Cr  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Highlights:       

• Successful pilot-scale production of Flavocide® conducted by Rallis
• Demonstration that Flavocide® can be produced at a consistent quality and yield at pre- commercial scale
• Flavocide® produced by Rallis to be used in planned testing activities to advance the registration process for Flavocide
• Rallis has capacity to produce Flavocide® in sufficient quantities for future supply to Bio-Gene’s commercial licensees

Announcing the above, Dr Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said,

““With a long-standing history of agrochemicals manufacturing and strategic partnerships with global customers; Rallis is committed to supporting the development and commercialization of next-gen sustainable solutions for the Crop Protection and allied sectors. Our partnership with Bio-Gene for the successful process development and scale-up of their patented nature-identical Flavocide® insecticide is testament to that commitment. While Rallis does not expect the business to be material at this stage, we look forward to continuing to work closely with Bio-Gene to enable the successful global commercialization of Flavocide-based solutions over the next few years.” 

A copy of the joint statement released is enclosed herewith.

Flavocide® is a nature-identical product based on Flavesone, a naturally occurring plant compound present in some eucalypts. Bio-Gene has developed a proprietary process to synthesise the molecule and produce it in commercial quantities. Bio-Gene owns all intellectual property created by its contractors relating to the synthesis of Flavocide®.

The post Bio-Gene and Rallis India Limited achieve key Flavocide® production milestone appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.